Abstract 3808: TM4SF1 Regulates Cell Cycle and ROS Status in Bladder Cancer Cells by Targeting FOXO3a Via PPARγ-SIRT1 Negative Feedback Loop
Rui Cao,Gang Wang,Kaiyu Qian,Liang Chen,Qingxuan Hu,Yu Xiao,Xinghuan Wang
DOI: https://doi.org/10.1158/1538-7445.am2017-3808
IF: 11.2
2017-01-01
Cancer Research
Abstract:Abstract Transmembrane 4 superfamily member 1 (TM4SF1) is a member of tetraspanin family, which locates in the cell membrane, functions as signal transducer to regulate cell development, growth and motility. Currently, TM4SF1 has been reported to be overexpressed in liver cancer, pancreatic cancer and colorectal cancer, but its role in bladder cancer (BCa) has not been illustrated. We have found that TM4SF1 was strongly upregulated in human bladder cancer tissues at both transcription and translation levels, compared with the paracancerous tissues and normal bladder tissues. This result was corroborated with our transcriptome analysis. Moreover, the tissue array data showed that TM4SF1 closely related with survival rate of BCa as the patients with high expression of TM4SF1 have a poorer prognosis. Furthermore, in vitro and in vivo studies suggested that proliferation of BCa cells was significantly suppressed by knockdown of TM4SF1. Moreover, downregulation of TM4SF1 induced G0/G1 phase cell cycle arrest and apoptosis possibly via induced reactive oxygen species (ROS) status in BCa cells. In addition, we observed that phosphorylated/total SIRT1 proteins were considerably reduced in the BCa cells lacking TM4SF1. In contrast, PPARγ as well as its target phosphorylated/total FOXO3a were strongly increased, an important downstream transcriptional factor of PPARγ/SIRT1 negative feedback loop, regulating cell cycle, apoptosis and ROS metabolism. Therefore, we treated the TM4SF1-silencing BCa cells with GW9662 (antagonist of PPARγ) and resveratrol (activator of SIRT1), showing a recovery of the G0/G1 phase cell cycle arrest and scavenge of ROS status. Interestingly, the increase of phosphorylated/total FOXO3a by knockdown of TM4SF1 could also be rescued by using GW9662 and resveratrol. In conclusion, our results suggested that TM4SF1 may regulate cell cycle and ROS status of BCa cells by targeting FOXO3a via the PPARγ-SIRT1 negative feedback loop. Note: This abstract was not presented at the meeting. Citation Format: Rui Cao, Gang Wang, Kaiyu Qian, Liang Chen, Qingxuan Hu, Yu Xiao, Xinghuan Wang. TM4SF1 regulates cell cycle and ROS status in bladder cancer cells by targeting FOXO3a via PPARγ-SIRT1 negative feedback loop [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 3808. doi:10.1158/1538-7445.AM2017-3808
What problem does this paper attempt to address?